Tectonic Therapeutic (TECX) Other financing activities (2018 - 2026)

Tectonic Therapeutic (TECX) has 9 years of Other financing activities data on file, last reported at $100000.0 in Q1 2026.

• On a quarterly basis, Other financing activities fell 99.94% year-over-year to $100000.0 in Q1 2026; TTM through Mar 2026 was -$4.1 million, a 102.27% decrease from a year earlier, with the FY2025 full-year figure at $173.1 million, up 10558.74% from the prior year.
• Other financing activities for Q1 2026 stood at $100000.0, up from -$4.2 million in the prior quarter.
• Over the last five years, Other financing activities for TECX reached as high as $177.3 million in Q1 2025 and fell as low as -$4.2 million in Q2 2025.
• Historically, Other financing activities has averaged $22.0 million across 5 years, with a median of $110000.0 in 2023.
• Across the five-year window, Other financing activities surged 1253.33% in 2024 and sank 795.0% in 2025, its largest moves.
• Year by year, Other financing activities stood at $58000.0 in 2022, then surged by 106.9% to $120000.0 in 2023, then jumped by 1253.33% to $1.6 million in 2024, then sank by 356.77% to -$4.2 million in 2025, then jumped by 102.4% to $100000.0 in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $100000.0 in Q1 2026, -$4.2 million in Q2 2025, and $177.3 million in Q1 2025.